MACROGENICS INC Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2012 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Macrogenics Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2012 to Q4 2024.
  • Macrogenics Inc Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $11.3M, a 158% increase year-over-year.
  • Macrogenics Inc Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $29.4M, a 60.2% increase year-over-year.
  • Macrogenics Inc annual Share-based Payment Arrangement, Expense for 2024 was $29.4M, a 60.2% increase from 2023.
  • Macrogenics Inc annual Share-based Payment Arrangement, Expense for 2023 was $18.4M, a 10.1% decline from 2022.
  • Macrogenics Inc annual Share-based Payment Arrangement, Expense for 2022 was $20.4M, a 11.6% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $29.4M $11.3M +$6.91M +158% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-20
Q3 2024 $22.5M $5.97M +$1.18M +24.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $21.4M $6.65M +$2.26M +51.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $19.1M $5.55M +$720K +14.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $18.4M $4.36M -$382K -8.06% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-20
Q3 2023 $18.8M $4.79M -$333K -6.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 $19.1M $4.39M -$909K -17.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $20M $4.83M -$441K -8.36% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $20.4M $4.74M -$671K -12.4% Oct 1, 2022 Dec 31, 2022 10-K 2025-03-20
Q3 2022 $21.1M $5.12M -$1.24M -19.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $22.3M $5.3M -$770K -12.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $23.1M $5.27M -$12K -0.23% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $23.1M $5.41M +$154K +2.93% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-07
Q3 2021 $23M $6.36M +$526K +9.02% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $22.4M $6.07M +$975K +19.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $21.5M $5.29M +$795K +17.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $20.7M $5.26M -$232K -4.23% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-15
Q3 2020 $20.9M $5.83M +$434K +8.04% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $20.5M $5.1M +$211K +4.32% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 $20.3M $4.49M +$692K +18.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
Q4 2019 $19.6M $5.49M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $5.4M +$825K +18% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $4.88M Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 $3.8M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q3 2018 $4.57M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q3 2013 $136K -$73.7K -35.1% Jul 1, 2013 Sep 30, 2013 10-Q 2013-11-12
Q3 2012 $210K Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.